American Headache Society (AHS)
- Guideline update to acute treatment of migraine for adults in the emergency department: the American headache society evidence assessment of parenteral pharmacotherapies (2025)
- Position Statement Update on calcitonin gene-related peptide-targeting therapies are a first-line option for the prevention of migraine (2024)
- Update on integrating new migraine treatments into clinical practice (2021)
- Acute treatment of migraine in children and adolescents (2019)
- How to apply the AHS evidence assessment of the acute treatment of migraine in adults to your patient with migraine (2016)
- Treatment of cluster headache (2016)
- The acute treatment of migraine in adults (2015)
American Academy of Neurology (AAN)
- Pharmacologic treatment for migraine prevention in adults (2026)
- Pharmacologic treatment for pediatric migraine prevention (2019)
- Acute treatment of migraine in children and adolescents (2019)
- Pharmacologic treatment for episodic migraine prevention in adults (2012)
American College of Physicians (ACP)
- Pharmacologic treatments of acute episodic migraine headache in outpatient settings: a clinical guidelines from American college of physicians (2025)
- Prevention of episodic migraine headache using pharmacologic treatments in outpatient settings: a clinical guideline from the American College of Physicians (2025)
Canadian Headache Society
European Academy of Neurology (EAN)
- Guidelines on the treatment of cluster headache (2023)
- Guideline on the management of medication-overuse headache (2020)
International Headache Society
National Institute for Health and Care Excellence (NICE)
Veterans Affairs/Department of Defense
Reviewer 1: Jessica Putney, PharmD, BCPP
Reviewer 2: Arianna Johnson, PharmD, BCPP
2026-2027 AAPP Resident and New Practitioner Committee